Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 JRS Pharma Receives EXCiPACT GMP Certification for the Production of MCC | Contract Pharma

What are you searching for?

Sign in
Breaking News

JRS Pharma Receives EXCiPACT GMP Certification for the Production of MCC

The certificate for Changzhou, China facilities helps drug manufacturers reduce efforts and costs.

By: Contract Pharma

Contract Pharma Staff

JRS PHARMA recently announced that the Rettenmaier Natural Fiber Manufacturing facilities in Changzhou, China, were awarded an EXCiPACT Certificate for Good Manufacturing Practices (GMP).
 
This document demonstrates that Rettenmaier Natural Fiber Manufacturing facilities operate according to the EXCiPACT Good Manufacturing Practice (GMP). The certificate helps drug manufacturers reduce efforts and costs as they need to either perform audits of new suppliers or commission third party physical audits to demonstrate GMP compliance. With the institution of new travel restrictions due to COVID-19, EXCiPACT certificates offer customers risk assessment assurance without the need to travel.
 
JRS PHARMA’s line of Microcrystalline Cellulose products produced at the Changzhou facility includes VIVAPUR, a premium tablet binder designed for specific formulation needs. MCC is an odorless, tasteless, white powder with a high degree of brightness, derived from highly purified wood pulp. With a wide range of chemical, technical, and economic benefits, MCC is one of the most widely used binder excipients for solid dosage forms.
 
For more information on VIVAPUR or any of JRS PHARMA’s excipient products, please visit www.jrspharma.com.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics